220 related articles for article (PubMed ID: 19999673)
1. A six-month prospective evaluation of personality traits, psychiatric symptoms and quality of life in ayahuasca-naïve subjects.
Barbosa PC; Cazorla IM; Giglio JS; Strassman R
J Psychoactive Drugs; 2009 Sep; 41(3):205-12. PubMed ID: 19999673
[TBL] [Abstract][Full Text] [Related]
2. Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil.
Barbosa PC; Giglio JS; Dalgalarrondo P
J Psychoactive Drugs; 2005 Jun; 37(2):193-201. PubMed ID: 16149333
[TBL] [Abstract][Full Text] [Related]
3. Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination.
Jiménez-Garrido DF; Gómez-Sousa M; Ona G; Dos Santos RG; Hallak JEC; Alcázar-Córcoles MÁ; Bouso JC
Sci Rep; 2020 Mar; 10(1):4075. PubMed ID: 32139811
[TBL] [Abstract][Full Text] [Related]
4. Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members.
Santos RG; Landeira-Fernandez J; Strassman RJ; Motta V; Cruz AP
J Ethnopharmacol; 2007 Jul; 112(3):507-13. PubMed ID: 17532158
[TBL] [Abstract][Full Text] [Related]
5. Psychological and neuropsychological assessment of regular hoasca users.
Barbosa PC; Strassman RJ; da Silveira DX; Areco K; Hoy R; Pommy J; Thoma R; Bogenschutz M
Compr Psychiatry; 2016 Nov; 71():95-105. PubMed ID: 27653781
[TBL] [Abstract][Full Text] [Related]
6. Consumption of ayahuasca by children and pregnant women: medical controversies and religious perspectives.
Labate BC
J Psychoactive Drugs; 2011; 43(1):27-35. PubMed ID: 21615005
[TBL] [Abstract][Full Text] [Related]
7. Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament.
Halpern JH; Sherwood AR; Passie T; Blackwell KC; Ruttenber AJ
Med Sci Monit; 2008 Aug; 14(8):SR15-22. PubMed ID: 18668010
[TBL] [Abstract][Full Text] [Related]
8. Ayahuasca and the process of regulation in Brazil and internationally: implications and challenges.
Labate BC; Feeney K
Int J Drug Policy; 2012 Mar; 23(2):154-61. PubMed ID: 21856141
[TBL] [Abstract][Full Text] [Related]
9. Health status of ayahuasca users.
Barbosa PC; Mizumoto S; Bogenschutz MP; Strassman RJ
Drug Test Anal; 2012; 4(7-8):601-9. PubMed ID: 22761152
[TBL] [Abstract][Full Text] [Related]
10. Acute Psychological Adverse Reactions in First-Time Ritual Ayahuasca Users: A Prospective Case Series.
Gómez-Sousa M; Jiménez-Garrido DF; Ona G; Dos Santos RG; Hallak JEC; Alcázar-Córcoles MÁ; Bouso JC
J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):163-171. PubMed ID: 33606432
[TBL] [Abstract][Full Text] [Related]
11. Forbidden therapies: Santo Daime, ayahuasca, and the prohibition of entheogens in Western society.
Blainey MG
J Relig Health; 2015 Feb; 54(1):287-302. PubMed ID: 24477460
[TBL] [Abstract][Full Text] [Related]
12. Ayahuasca, Personality and Acute Psychological Effects in Neo-Shamanic and Religious Settings in Uruguay.
Apud I; Scuro J; Rodríguez L; Hernandez G; Carrera I; Lozano F; Retta JI
J Psychoactive Drugs; 2023; 55(5):581-591. PubMed ID: 37750012
[TBL] [Abstract][Full Text] [Related]
13. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
Hamill J; Hallak J; Dursun SM; Baker G
Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
[TBL] [Abstract][Full Text] [Related]
14. Analytical techniques for the determination of tryptamines and β-carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo-shamanic urban practices.
Gaujac A; Navickiene S; Collins MI; Brandt SD; de Andrade JB
Drug Test Anal; 2012; 4(7-8):636-48. PubMed ID: 22577086
[TBL] [Abstract][Full Text] [Related]
15. Ayahuasca in adolescence: a preliminary psychiatric assessment.
Da Silveira DX; Grob CS; de Rios MD; Lopez E; Alonso LK; Tacla C; Doering-Silveira E
J Psychoactive Drugs; 2005 Jun; 37(2):129-33. PubMed ID: 16149324
[TBL] [Abstract][Full Text] [Related]
16. Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study.
Bouso JC; González D; Fondevila S; Cutchet M; Fernández X; Ribeiro Barbosa PC; Alcázar-Córcoles MÁ; Araújo WS; Barbanoj MJ; Fábregas JM; Riba J
PLoS One; 2012; 7(8):e42421. PubMed ID: 22905130
[TBL] [Abstract][Full Text] [Related]
17. Altered State of Consciousness and Mental Imagery as a Function of N, N-dimethyltryptamine Concentration in Ritualistic Ayahuasca Users.
Ramaekers JG; Mallaroni P; Kloft L; Reckweg JT; Toennes SW; van Oorsouw K; Mason NL
J Cogn Neurosci; 2023 Sep; 35(9):1382-1393. PubMed ID: 37159257
[TBL] [Abstract][Full Text] [Related]
18. Hallucinogens and redemption.
de Rios MD; Grob CS; Baker JR
J Psychoactive Drugs; 2002; 34(3):239-48. PubMed ID: 12422934
[TBL] [Abstract][Full Text] [Related]
19. Ayahuasca in adolescence: Qaualitative results.
de Rios MD; Grob CS; Lopez E; da Silviera DX; Alonso LK; Doering-Silveira E
J Psychoactive Drugs; 2005 Jun; 37(2):135-9. PubMed ID: 16149325
[TBL] [Abstract][Full Text] [Related]
20. Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution.
Uthaug MV; van Oorsouw K; Kuypers KPC; van Boxtel M; Broers NJ; Mason NL; Toennes SW; Riba J; Ramaekers JG
Psychopharmacology (Berl); 2018 Oct; 235(10):2979-2989. PubMed ID: 30105399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]